Secondary Endpoint: Change in A1C Over Time From Baseline at 52 Weeks<sup>1,2 a,b</sup>

Accordion title open

Show Description

Accordion title close

Close Description

Secondary Endpoint: Change in A1C Over Time From Baseline at 52 Weeks^{1,2 a,b}

A line graph showing the change in A1C over time from baseline to 52 weeks for Mounjaro vs placebo. At week 0, the mean baseline A1C was 8.0%. At week 52, patients taking Mounjaro 5 mg (n=32) had a -2.1 percent change from baseline; patients taking Mounjaro 10 mg (n=33) had a -2.3 percent change from baseline; patients taking pooled Mounjaro (5 mg and 10 mg) (n=65) had a -2.2 percent change from baseline; and patients taking placebo who then switched to Mounjaro 5 mg (n=34) at week 30 had a -1.5 percent change from baseline to week 52.

Secondary Endpoint: Change in A1C Over Time From Baseline at 52 Weeks1,2 a,b

Secondary Endpoint: Change in A1C Over Time From Baseline at 52 Weeks^{1,2 a,b}